Announcements

3 September 2025
Join Us at the MDPI at the University of Toronto Career Fair, 23 September 2025, Toronto, ON, Canada


Date: 23 September 2025
Time: 11:00 a.m.–4:30 p.m
Location: The Chelsea Hotel, 33 Gerrard Street West, Toronto

MDPI is thrilled to announce our participation in the University of Toronto’s largest career fair, taking place at the St. George Downtown Campus. This exciting event brings together thousands of students, graduates, and professionals looking to connect with top employers and explore career opportunities.

We invite all attendees to visit the MDPI booth to discover how you can be part of one of the world’s leading open access academic publishers. Whether you are passionate about scientific research, editorial work, marketing, or supporting global innovation in publishing, we want to meet YOU!

What to expect at our booth:

  • Learn more about MDPI’s mission and global impact;
  • Explore exciting career opportunities in publishing, editorial, communications, and more;
  • Network with our team and ask questions about working at MDPI.

Whether you’re just starting your career or looking to take the next step, don’t miss this opportunity to connect with MDPI. Bring your resume, your curiosity, and your questions—we look forward to seeing you there!

For additional information on the Career Fair and Open MDPI positions, please visit the following links:

1 September 2025
MDPI INSIGHTS: The CEO’s Letter #26 – CUJS, Head of Ethics, Open Peer Review, AIS 2025, Reviewer Recognition

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Society of China University Journals (CUJS) visit to MDPI Basel

In August, we had the pleasure of welcoming a delegation from the Society of China University Journals (CUJS) to our Basel headquarters. The visit was part of CUJS’s broader European tour, which included meetings with several major publishing organizations.

Purpose of the visit

The delegation’s stop in Basel involved an introductory meeting and knowledge-sharing with a view to identifying potential collaboration opportunities with MDPI. The CUJS team shared an overview of the Chinese scientific publishing landscape, including recent policy developments, and gave us insights into the journals and services they operate across China’s academic institutions.

MDPI presentations

We used the opportunity to introduce CUJS to MDPI’s mission, structure, and recent achievements. I presented on the latest developments at MDPI and our role in supporting global open access, addressing many follow-up questions from the delegation. Warm thanks are due to the following colleagues for their contributions to the session:

  • Liliane Auwerter (Conference Organizer, Scientific Officer and Sustainability Specialist) shared an overview of our editorial process, including the quality indicators we use to track peer-review performance.
  • Renato Merki (Publication Ethics Assistant) presented on behalf of our Research Integrity and Ethics team, emphasizing our commitment to responsible publishing.
  • Silvano Bonfatti (Product Manager) introduced the JAMS platform, highlighting how it supports efficient journal management for editors and publishers alike.
  • Aimar Xiong (Publisher, Section Managing Editor) and Giuliano Braccini (Office Manager) facilitated the meeting, offering clarity in response to specific questions, building the relationship during and beyond the meeting itself.

“Building relationships with organizations such as CUJS allows us to increase our visibility and reputation”

Why is this important?

China is one of the world’s largest producers of scientific research, with its universities and research institutes playing a key role in global scholarly publishing. Building strong relationships with influential organizations such as CUJS allows us to increase our visibility and reputation vis-à-vis the Chinese academic community, share best practices, learn from differing publishing models, and explore collaborations that have the potential to enhance the quality, reach, and diversity of our journals.

Looking ahead

It was a productive and friendly exchange that reflected our shared commitment to advancing scholarly communication and improving journal publishing practices. We value these visits, which allow us to create collaborations with stakeholders in the global academic community.

Our Basel office is a hub for hosting international delegations, partners, and collaborators. We look forward to creating more global connections that support our mission.

Impactful Research

Appointment of Dr. Tim Tait-Jamieson as Head of Publication Ethics

As part of our ongoing commitment to research integrity and publishing excellence, I am delighted to announce that we have appointed Dr. Tim Tait-Jamieson as Head of Publication Ethics.

In this role, Tim will lead the development of our ethics strategy and oversee the continued growth of the Publication Ethics Department, which is based across our offices in Basel, Manchester, Belgrade/Novi Sad, and Cluj. Guided by the principles of effective prevention and efficient resolution, the department plays an essential role in ensuring the highest standards of integrity throughout our editorial processes.

Department focus

Working closely with internal teams and external partners, the Publication Ethics Department focuses on refining our policies, aligning our operations with international best practices, and addressing complex cases with fairness and transparency. This work is critical in supporting our editors, reviewers, and authors, reinforcing MDPI’s contribution to the global dialogue on research integrity.

“Research integrity is something to which we all contribute through our daily work at MDPI”

About Tim

Tim joined MDPI in 2021 and has held several roles within the Publication Ethics Department, most recently serving as Research Integrity Lead. Based in our Basel office, he brings a strong academic background, with a Ph.D. in Geography from the University of Fribourg, Switzerland, and a proven track record of leadership in research integrity.

Research integrity is something to which we all contribute through our daily work at MDPI. I look forward to Tim’s leadership as we continue investing in the people, processes, and partnerships that uphold the trust and credibility of scholarly publishing.

Read more:

Inside MDPI

How and why MDPI offers Open Peer Review

At MDPI, we are committed to advancing openness and transparency in scholarly publishing. One area where we’ve taken a leadership role is peer review. Since 2014, MDPI has offered authors the option of open peer review, giving them the opportunity to publish reviewer comments alongside their papers. Each year, more authors are choosing this path, helping to build trust in the editorial process and provide valuable context for the research we publish.

Jack McKenna (Senior Content Specialist, MDPI) recently wrote an informative piece looking at the impact and importance of open peer review at MDPI. He highlights how this approach not only benefits readers but also gives well-deserved recognition to our reviewers, who generously dedicate their time and expertise to the academic community.

I encourage you to read this blogpost to see how MDPI is helping set standards for transparency in scholarly publishing.

Coming Together for Science

Recap of MDPI’s AIS 2025 Conference in Kuala Lumpur

Entering the month of August, we held The 2nd International Conference on AI Sensors and Transducers (AIS 2025) in Kuala Lumpur, Malaysia.

“AIS is quickly becoming a premier event in the field”

The second edition of AIS brought together 335 attendees from across Asia and beyond, including participants from China, Japan, Korea, and Southeast Asia. The event, chaired by Prof. Dr. Toshihiro Itoh (University of Tokyo), Prof. Dr. Sang-Woo Kim (Yonsei University), and Prof. Dr. Chengkuo Lee (National University of Singapore), continues to grow in reputation and has become an important platform for researchers and students to present their work, exchange ideas, and build international collaborations.

AIS is quickly becoming a premier event in the field, with participants highlighting its quality of service, its expanding academic network, and the value it delivers in the context of tightening research budgets in the region.

It was also excellent to see our new MDPI journal AI Sensors, which originated from a conference topic, host a successful launch party at the event.

Highlights from participant feedback:

  • Southeast University (China) sent a student delegation and considers AIS a regular fixture for Ph.D. students in need of international conference experience.
  • CAS Aerospace Information Research Institute sent a 10-member delegation and plans to further promote AIS internally.
  • Japanese researchers regard AIS as a must-attend event, placing it on a par with IEEE conferences and citing the benefits of networking and exchange.
  • Korean academics praised the organization and noted improved perceptions of MDPI among their institutions, viewing AIS as a strategic opportunity to deepen engagement in the region.

Award winners

We recognized the recipients of the Best Presentation, Best Scientist, Best Poster, and Best Student Paper awards, whose contributions set a standard for academic excellence. The full award announcement is available here.

Looking ahead

The 3rd International Conference on AI Sensors and Transducers will be held from 5 to10 August 2026 in Jeju, Korea. The General Chairs will be Prof. Inkyu Park (Korea Advanced Institute of Science and Technology), Prof. Zhou Li (Tsinghua University), Prof. Xinge Yu (City University of Hong Kong), and Prof. Chengkuo Lee (National University of Singapore). We look forward to bringing together innovators, researchers and experts who are shaping the future at the intersection of sensors, sensing technology, transducers and artificial intelligence.

Thank you

Our conference team managed this event with great agility and professionalism and are already planning improvements to make the conference even more accessible. Special thanks to the National University of Singapore for their support, and to our entire conference team and collaborators for their dedication.

AIS is gaining momentum, and we look forward to supporting its role as a bridge between MDPI and the global academic community.

“Our conference team managed this event with great agility and professionalism”

Closing Thoughts

Recognizing our outstanding reviewers

As we close this edition of the newsletter, I would like to spotlight MDPI’s 2024 Outstanding Reviewer Awards, which showcase a group of winners whose contributions often go unseen but are essential to the integrity of scholarly publishing: our reviewers.

In 2024, more than 215,000 reviewers dedicated their time and expertise to MDPI journals. From this community, we are proud to recognize 356 recipients of the Outstanding Reviewer Awards, who went above and beyond by providing timely, thorough and constructive feedback.

These awards are not only a token of our appreciation but also a reflection of the values we stand for: rigor, fairness and collaboration in advancing science.

To explore the full list of awardees across disciplines, from life sciences to the humanities, please visit the following pages:

About MDPI Awards

To recognize the academic community, MDPI journals regularly offer various awards to researchers in specific fields. Serving as a source of recognition and inspiration, these awards help increase the influence of scholars who have been credited with outstanding achievements and are making a significant contribution to the advancement of their respective fields.

To explore more opening Outstanding Reviewer Awards, please click here.

To all our reviewers: thank you for being the foundation of trust that makes open access publishing possible!

Stefan Tochev
Chief Executive Officer
MDPI AG

26 August 2025
Viruses | Selected Papers on Phage Therapy


1. “Pseudomonas Phage ZCPS1 Endolysin as a Potential Therapeutic Agent”
by Fatma Abdelrahman, Rutuja Gangakhedkar, Gokul Nair, Gamal El-Didamony, Ahmed Askora, Vikas Jain and Ayman El-Shibiny
Viruses 2023, 15(2), 520; https://doi.org/10.3390/v15020520
Available online: https://www.mdpi.com/1999-4915/15/2/520

2. “Characterization and Anti-Biofilm Activity of Lytic Enterococcus Phage vB_Efs8_KEN04 against Clinical Isolates of Multidrug-Resistant Enterococcus faecalis in Kenya”
by Oumarou Soro, Collins Kigen, Andrew Nyerere, Moses Gachoya, Martin Georges, Erick Odoyo and Lillian Musila
Viruses 2024, 16(8), 1275; https://doi.org/10.3390/v16081275
Available online: https://www.mdpi.com/1999-4915/16/8/1275

3. “Short-Term Outcomes of Phage-Antibiotic Combination Treatment in Adult Patients with Periprosthetic Hip Joint Infection”
by Eugeny Fedorov, Alexander Samokhin, Yulia Kozlova, Svetlana Kretien, Taalai Sheraliev, Vera Morozova, Nina Tikunova, Alexey Kiselev and Vitaliy Pavlov
Viruses 2023, 15(2), 499; https://doi.org/10.3390/v15020499
Available online: https://www.mdpi.com/1999-4915/15/2/499

4. “Design of Phage-Cocktail–Containing Hydrogel for the Treatment of Pseudomonas aeruginosa–Infected Wounds”
by Fatemeh Shafigh Kheljan, Farzam Sheikhzadeh Hesari, Mohammad Sadegh Aminifazl, Mikael Skurnik, Sophia Goladze and Gholamreza Zarrini
Viruses 2023, 15(3), 803; https://doi.org/10.3390/v15030803
Available online: https://www.mdpi.com/1999-4915/15/3/803

5. “Successful Bacteriophage-Antibiotic Combination Therapy against Multidrug-Resistant Pseudomonas aeruginosa Left Ventricular Assist Device Driveline Infection”
by Karlis Racenis, Janis Lacis, Dace Rezevska, Laima Mukane, Aija Vilde, Ints Putnins, Sarah Djebara, Maya Merabishvili, Jean-Paul Pirnay, Marika Kalnina et al.
Viruses 2023, 15(5), 1210; https://doi.org/10.3390/v15051210
Available online: https://www.mdpi.com/1999-4915/15/5/1210

6. “Phage and Antibiotic Combinations Reduce Staphylococcus aureus in Static and Dynamic Biofilms Grown on an Implant Material”
by Hyonoo Joo, Sijia M. Wu, Isha Soni, Caroline Wang-Crocker, Tyson Matern, James Peter Beck and Catherine Loc-Carrillo
Viruses 2023, 15(2), 460; https://doi.org/10.3390/v15020460  
Available online: https://www.mdpi.com/1999-4915/15/2/460

7. “The Lytic Activity of Bacteriophage ZCSE9 against Salmonella enterica and Its Synergistic Effects with Kanamycin”
by Abdallah S. Abdelsattar, Mohamed Atef Eita, Zainab K. Hammouda, Shrouk Mohamed Gouda, Toka A. Hakim, Aghapy Yermans Yakoup, Anan Safwat and Ayman El-Shibiny
Viruses 2023, 15(4), 912; https://doi.org/10.3390/v15040912
Available online: https://www.mdpi.com/1999-4915/15/4/912

8. “Biological Properties of 12 Newly Isolated Acinetobacter baumannii-Specific Bacteriophages”
by Natalia Bagińska, Marek Adam Harhala, Martyna Cieślik, Filip Orwat, Beata Weber-Dąbrowska, Krystyna Dąbrowska, Andrzej Górski and Ewa Jończyk-Matysiak
Viruses 2023, 15(1), 231; https://doi.org/10.3390/v15010231
Available online: https://www.mdpi.com/1999-4915/15/1/231

9. “Effective Treatment of Staphylococcus aureus Intramammary Infection in a Murine Model Using the Bacteriophage Cocktail StaphLyse™”
by Eric Brouillette, Guillaume Millette, Suzanne Chamberland, Jean-Pierre Roy, Céline Ster, Tadele Kiros, Stephanie Hickey, Lauren Hittle, Joelle Woolston and François Malouin
Viruses 2023, 15(4), 887; https://doi.org/10.3390/v15040887
Available online: https://www.mdpi.com/1999-4915/15/4/887

10. “Combinations of Bacteriophage Are Efficacious against Multidrug-Resistant Pseudomonas aeruginosa and Enhance Sensitivity to Carbapenem Antibiotics”
by Christopher J. Kovacs, Erika M. Rapp, William R. Rankin, Sophia M. McKenzie, Brianna K. Brasko, Katherine E. Hebert, Beth A. Bachert, Andrew R. Kick, F. John Burpo and Jason C. Barnhill
Viruses 2024, 16(7), 1000; https://doi.org/10.3390/v16071000
Available online: https://www.mdpi.com/1999-4915/16/7/1000

26 August 2025
Viruses | Selected Papers on Veterinary Virology


1. “Development of a Ferritin Protein Nanoparticle Vaccine with PRRSV GP5 Protein”
by Xinjian Chang, Jun Ma, Yanrong Zhou, Shaobo Xiao, Xun Xiao and Liurong Fang
Viruses 2024, 16(6), 991; https://doi.org/10.3390/v16060991
Available online: https://www.mdpi.com/1999-4915/16/6/991

2. “Genetic Characterization and Pathogenicity of a Recombinant Porcine Reproductive and Respiratory Syndrome Virus Strain in China”
by Yan Ouyang, Yingbing Du, Hejin Zhang, Jiahui Guo, Zheng Sun, Xiuxin Luo, Xiaowei Mei, Shaobo Xiao, Liurong Fang and Yanrong Zhou
Viruses 2024, 16(6), 993; https://doi.org/10.3390/v16060993
Available online: https://www.mdpi.com/1999-4915/16/6/993

3. “The Full-Genome Analysis and Generation of an Infectious cDNA Clone of a Genotype 6 Hepatitis E Virus Variant Obtained from a Japanese Wild Boar: In Vitro Cultivation in Human Cell Lines”
by Putu Prathiwi Primadharsini, Masaharu Takahashi, Tsutomu Nishizawa, Yukihiro Sato, Shigeo Nagashima, Kazumoto Murata and Hiroaki Okamoto
Viruses 2024, 16(6), 842; https://doi.org/10.3390/v16060842
Available online: https://www.mdpi.com/1999-4915/16/6/842

4. “Prevalence, Time of Infection, and Diversity of Porcine Reproductive and Respiratory Syndrome Virus in China”
by Chaosi Li, Aihua Fan, Zhicheng Liu, Gang Wang, Lei Zhou, Hongliang Zhang, Lv Huang, Jianfeng Zhang, Zhendong Zhang and Yan Zhang
Viruses 2024, 16(5), 774; https://doi.org/10.3390/v16050774
Available online: https://www.mdpi.com/1999-4915/16/5/774

5. “Molecular Survey on Porcine Parvoviruses (PPV1-7) and Their Association with Major Pathogens in Reproductive Failure Outbreaks in Northern Italy”
by Giulia Faustini, Claudia Maria Tucciarone, Giovanni Franzo, Anna Donneschi, Maria Beatrice Boniotti, Giovanni Loris Alborali and Michele Drigo
Viruses 2024, 16(1), 157; https://doi.org/10.3390/v16010157  
Available online: https://www.mdpi.com/1999-4915/16/1/157

6. “Short Treatment of 42 Days with Oral GS-441524 Results in Equal Efficacy as the Recommended 84-Day Treatment in Cats Suffering from Feline Infectious Peritonitis with Effusion—A Prospective Randomized Controlled Study”
by Anna-M. Zuzzi-Krebitz, Katharina Buchta, Michèle Bergmann, Daniela Krentz, Katharina Zwicklbauer, Roswitha Dorsch, Gerhard Wess, Andrea Fischer, Kaspar Matiasek, Anne Hönl et al.
Viruses 2024, 16(7), 1144; https://doi.org/10.3390/v16071144
Available online: https://www.mdpi.com/1999-4915/16/7/1144

7. “Recent Molecular Characterization of Porcine Rotaviruses Detected in China and Their Phylogenetic Relationships with Human Rotaviruses”
by Mengli Qiao, Meizhen Li, Yang Li, Zewei Wang, Zhiqiang Hu, Jie Qing, Jiapei Huang, Junping Jiang, Yaqin Jiang, Jinyong Zhang, Chunliu Gao, Chen Yang, Xiaowen Li and Bin Zhou
Viruses 2024, 16(3), 453; https://doi.org/10.3390/v16030453
Available online: https://www.mdpi.com/1999-4915/16/3/453

8. “Spatial Transmission Characteristics of the Bluetongue Virus Serotype 3 Epidemic in The Netherlands, 2023”
by Gert-Jan Bounder, Thomas J. Hagenaars, Melle Holwerda, Marcel A. H. Spierenburg, Piet A. van Rijn, Arco N. van der Spek and Armin R. W. Elbers
Viruses 2024, 16(4), 625; https://doi.org/10.3390/v16040625
Available online: https://www.mdpi.com/1999-4915/16/4/625

9. “Serologic, Virologic and Pathologic Features of Cats with Naturally Occurring Feline Infectious Peritonitis Enrolled in Antiviral Clinical Trials”
by Brian G. Murphy, Diego Castillo, N E Neely, Amir Kol, Terza Brostoff, Chris K. Grant and Krystle L. Reagan
Viruses 2024, 16(3), 462; https://doi.org/10.3390/v16030462
Available online: https://www.mdpi.com/1999-4915/16/3/462

10. “Geographical Expansion of Avian Metapneumovirus Subtype B: First Detection and Molecular Characterization of Avian Metapneumovirus Subtype B in US Poultry”
by Muhammad Luqman, Naveen Duhan, Gun Temeeyasen, Mohamed Selim, Sumit Jangra and Sunil Kumar Mor
Viruses 2024, 16(4), 508; https://doi.org/10.3390/v16040508
Available online: https://www.mdpi.com/1999-4915/16/4/508

25 August 2025
Viruses | Behind the Paper: “Picornavirus Evolution: Genomes Encoding Multiple 2ANPGP Sequences—Biomedical and Biotechnological Utility”

“Picornavirus Evolution: Genomes Encoding Multiple 2ANPGP Sequences—Biomedical and Biotechnological Utility”
by Garry A. Luke, Lauren S. Ross, Yi-Ting Lo, Hsing-Chieh Wu and Martin D. Ryan
Viruses 2024, 16(10), 1587; https://doi.org/10.3390/v16101587
Available online: https://www.mdpi.com/1999-4915/16/10/1587

This accompaniment to the publication proper tells the story behind the paper, detailing the highs and lows along the way.

First identified in foot-and-mouth disease virus (FMDV), the 2A oligopeptide sequence allows multiple discrete proteins to be synthesized from a single strand of virus RNA, which also functions as a messenger RNA (mRNA). The short 2A peptide, 18 amino acids (aa) in length, comprises two parts, an N-terminal region (without high sequence conservation) and a conserved motif comprising the seven C-terminal residues of 2A and the N-terminal proline of the downstream protein 2B (-D[V/I]ExNPGP, underlined proline comprises the N-terminal residue of 2B). Briefly, the 2A region of the polyprotein manipulates the ribosome to “skip” the synthesis of the glycyl-prolyl peptide bond at its own carboxyl terminus leading to the release of the nascent protein followed by translation of the remaining downstream sequence (1).

Probing databases with this “signature” motif, 2ANPGP sequences have been reported in several viral genomes within different genera of the Picornaviridae, other positive strand viruses such as the Dicistroviridae and Iflaviridae(2-3), double-strand RNA viruses belonging to the Totiviridae/Reoviridae  (4) families, and in a tentatively assigned negative-sense single-stranded RNA virus of the Bunyaviridae family (3). From bioinformatics analysis, 2A-like cellular sequences have also been identified in the open reading frames (ORFs) of CATERPILLER proteins that are involved in innate immunity(5), non-LTR retrotransposons (non-LTRs) within the genome of trypanosomes(6), and a wide range of primitive marine organisms, including sponges, sea slugs, purple sea urchins, acorn worms and amphioxi (7). Linking proteins with 2A or 2A-like peptide sequences results in cellular expression of multiple, discrete proteins derived from a single ORF. Of the many 2A peptides identified to date, four viral 2As have been widely used in biotechnology and biomedicine: FMDV (F2A; -QLLNFDLLKLAGDVESNPGP-), equine rhinitis A virus (E2A; -QCTNYALLKLAGDVESNPGP-), porcine teschovirus-1 (P2A; -ATNFSLLKQAGDVEENPGP-), and Thosea asigna virus (T2A; -EGRGSLLTCGDVESNPGP-) (8). These sequences are now being used to treat cancer, to produce antibodies and antigens that can be used in vaccine production, genome (DNA and RNA) editing in cell/gene therapies, and engineering multi-gene biosynthetic pathways amongst a host of other biomedical/biotechnological applications (https://www.st-andrews.ac.uk/ryanlab/Index.html). The positive strand RNA viruses typically possess one 2A/2A-like sequence, but some viruses have two, three, or more motifs. The primary aims of our recent paper were to identify genomes containing more than a single 2ANPGP sequence in the family Picornaviridae, describe their occurrence in different viral genera, and determine their cleavage activity vis à vis potential biotechnology applications.

As a first step, in silico searches of picornavirus proteinase/polymerase and classical 2ANPGP sequences (-D(V/I)ExNPGP-; -G(V/I)ExNPGP-; “x” is any amino acid which is not conserved) were made by screening the sequences currently available in the NCBI’s (National Centre for Biotechnology Information) growing database. Alignment of 3CD amino acid sequences revealed this family evolved into five “supergroups” (SG1-5; Caphthovirinae, Kodimesavirinae, Ensavirinae, Paavivirinae, and Heptrevirinae) with 2ANPGP sequences found only within supergroups 1 and 4. Interestingly, the nature of the 2A region of the picornavirus polyprotein was highly correlated with this division of the family (9). In the case of the Caphthovirinae (SG1), most if not all viruses encoded a single copy of 2ANPGP whilst members of the Paavivirinae (SG4) exhibited the highest variability in their 2A region with many viruses encoding multiple 2ANPGP sequences (e.g., aali-, avisi-, grusopi-, kunsagi-, limnipi-, parecho-, and potamipiviruses) (Figure 1). For instance, the Duck Picornavirus GL/12 (aalivirus A1) has six 2A proteins (Figure 2, Panel A) — the first four all have C-terminal region (~25aa) similarity with the aphthovirus-like 2ANPGP sequences whilst 2A5 and 2A6 closely resemble avihepatovirus 2A2 and 2A3, respectively (10).

Figure 1

 

Figure 2

These multiple 2ANPGP sequences were then tested for translational recoding activity using our pSTA1 dual reporter system [GFP-2A-GUS] (2). Plasmids containing 2A-like sequences were used to programme a Wheat Germ Extract coupled transcription/translation system and proteins resolved by SDS-PAGE separation (Figure 2, Panel B). Constructs were evaluated for recoding activity relative to the positive FMDV 2A control by visual inspection: [GFP2A] + GUS for high activity, [GFP-2A-GUS] + GUS + [GFP2A] for high/moderate activity, and [GFP-2A-GUS] for no activity. Careful analysis of the translational profiles was both surprising and bewildering. Several sequences displayed higher activity than FMDV 2A and could prove useful for future biotechnological applications: aalivirus A1/B1 2A1-2A4; Grusopivirus A1/C 2A1-2A3; Limnipivirus A1 2A1, B1 2A2, C1 2A1, D1 2A1-3; and Mosavirus B1 2A1 and 2A2 (Table 1). In a number of cases, however, only [GFP2A] could be detected: kunsagivirus C1 2A1, limnipivirus A1 2A2, limnipivirus B1 2A1, potamipivirus B1 2A2, Wuhan carp picornavirus (WCP) 2A1/2A2/2A3, and Wenzhou picorna-like virus 48 (WP-LV48) 2A1/2A2 and 2A3. In terms of our current model of ribosome skipping and virus functionality, an enigma wrapped in a conundrum. In our study, we draw a parallel with no-go decay (NGD), a eukaryote translation-coupled mRNA quality control system (11). NGD, one of at least three mRNA surveillance pathways that include nonsense-mediated decay (NMD) and non-stop decay (NSD), is triggered by the presence of mRNA secondary structures leading to ribosome stalling. Persistent stalling sets in motion a cascade of events that aim to inhibit translation re-initiation on the defective mRNA and simultaneously remove faulty mRNAs and recycle the ribosomes in a process mediated by the Pelota/Hbs1/ABCE1 complex (12). Consistent with our observations, this would produce [GFP2A] alone, although the NGD pathway implies degradation of the virus RNA, which is perhaps the most important question yet to be addressed.

Table 1. 2A/2A-like sequences used for protein co-expression

Genus

Species

2ANPGP

Amino Acid Sequence

Accession no

Positive-stranded RNA viruses: Picornaviridae 

Aalivirus

AalV-A1

2A1

LLTSEGATNSSLLKLAGDVEENPGP

KJ000606

 

 

2A2

FEMPYDDPEWDRLLQAGDIEQNPGP

 

 

 

2A3

PIPARPDPQWNNLQQAGDVEMNPGP

 

 

 

2A4

EHFNQTGGWVPDLTQCGDVESNPGP

 

 

AalV-B1

2A1

ATTLQVSEYLKDLTIDGDVESNPGP

MH453803

 

 

2A2

LKVKKLEGDYVRDLTQEGVEPNPGP

 

 

 

2A3

SVRVTDAGWVRDLTVDGDVESNPGP

 

 

 

2A4

VFKCHDKCWVDDLTNCGDVESNPGP

 

Grusopivirus

GrV-A1

2A1

FEKHVKPWRSQEDLSKEGIEPNPGP

KY312544

 

 

2A2

ITDNRYKETDAKWLSRYGVEMNPGP

 

 

 

2A3

VTQDLYAATNQDQLSNQGIESNPGP

 

 

GrV-C

2A1

YFEERSPHPTQKELGQFGVETNPGP

MK443503

 

 

2A2

ENNSNYDERDAKHLSRYGIEMNPGP

 

 

 

2A3

CVCTRWSPTMQSELGKYGIEKNPGP

 

Limnipivirus

A1

2A1

CKEFVRESDNQELLKCGDVESNPGP

JX134222

 

B1

2A2

IDLVQAAYSRMRLLLSGDVEQNPGP

KF306267

 

C1

2A1

KLLEQILAYKRDLTACGDVESNPGP

KF874490

 

D1

2A1

EEEVDWGVGRMRLKMSGDVEENPGP

MG600094

 

 

2A2

AVHLLVTWMRRRLTLSGDIESNPGP

 

 

 

2A3

DLRAVKSFIESQLMRAGDVERNPGP

 

Mosavirus

B1

2A1

ESRGTGNCDATTISQCGDVETNPGP

KY855435

 

 

2A2

YVRRSANRTAADISQDGDVETNPGP

 

References

  1. Donnelly, M.L.L.; Luke, G.A.; Mehotra, A.; Li, X.; Hughes, L.E.; Gani, D.; Ryan, M.D. Analysis of the aphthovirus 2A/2B polyprotein “cleavage” mechanism indicates not a proteolytic reaction, but a novel translational effect: A putative ribosomal “skip”. Gen. Virol. 2001, 82, 1013–1025. https://doi.org/10.1099/0022-1317-82-5-1013. PMID: 11297676.
  2. Luke, G.A.; de Felipe, P.; Lukashev, A.; Kallioinen, S.E.; Bruno, E.A.; Ryan, M.D. The occurrence, function, and evolutionary origins of “2A-like” sequences in virus genomes. Gen. Virol. 2008, 89, 1036–1042. https://doi.org/10.1099/vir.0.83428-0. PMID: 18343847; PMCID: PMC2885027.
  3. de Lima, J.G.S.; Lanza, D.C.F. 2A and 2A-like sequences: Distribution in different virus species and applications in biotechnology. Viruses 2021, 13, 2160. https://doi.org/3390/v13112160. PMID: 34834965; PMCID: PMC8623073.
  4. de Lima, J.G.S.; Teixeira, D.G.; Freitas, T.T.; Lima, J.P.M.S.; Lanza, D.C.F. Evolutionary origin of 2A-like sequences in Totiviridae genomes. Virus Res. 2019, 259, 1–9. https://doi.org/1016/j.virusres.2018.10.011. PMID: 30339789.
  5. Brown, J.D.; Ryan, M.D. Ribosome “Skipping”: “Stop-Carry On” or “StopGo” Translation. In Recoding: Expansion of Decoding Rules Enriches Gene Expression; Atkins, J.F., Gesteland, R.F., Eds.; Springer: New York, NY, USA, 2010; pp. 101–122.
  6. Heras, S.R.; Thomas, M.C.; García-Canadas, M.; de Felipe, P.; García-Perez, J.L.; Ryan, M.D.; Lopez, M.C. L1Tc Non-LTR Retrotransposons from Trypanosoma Cruzi contain a functional viral-like self-cleaving 2A Sequence in frame with the active proteins they encode. Mol. Life Sci. 2006, 63, 1449-1460. https://doi.org/10.1007/s00018-006-6038-2. PMID: 16767356; PMCID: PMC11136212
  7. Odon, V.; Luke, G.A.; Roulston, C.; de Felipe, P.; Ruan, L.; Escuin-Ordinas, H.; Brown, J.D.; Ryan, M.D.; Sukhodub, A. APE-Type Non-LTR retrotransposons of multicellular organisms encode virus-like 2A oligopeptide sequences, which mediate translational recoding during protein synthesis. Biol. Evol. 2013, 30, 1955–1965. https://doi.org/10.1093/molbev/mst102. PMID: 23728794; PMCID: PMC3708506.
  8. Luke, G.A.; Ryan, M.D. The 2A story—The end of the beginning. In Beyond the Blueprint—Decoding the Elegance of Gene Expression; Siefi, M., Ed.; InTech: Rijeka, Croatia, 2024; pp 116–145. https://doi.org/10.5772/intechopen.1004928.
  9. Zell, R.; Knowles, N.J.; Simmonds, P.A. Proposed division of the family Picornaviridae into subfamilies based on phylogenetic relationships and functional genomic organization. Virol. 2021, 166, 2927–2935. https://doi.org/10.1007/s00705-021-05178-9. PMID: 34350513; PMCID: PMC8421316.
  10. Wang, X.; Liu, N.; Wang, F.; Ning, K.; Li, Y.; Zhang, D. Genetic characterization of a novel duck-origin picornavirus with six 2A proteins. Gen. Virol. 2014, 95, 1289–1296. https://doi.org/10.1099/vir.0.063313-0. PMID: 24659102.
  11. Doma, M.K.; Parker, R. Endonucleolytic cleavage of eukaryotic mRNAs with stalls in translation elongation. Nature 2006, 440, 561–564. https://doi.org/10.1038/nature04530. PMID: 16554824; PMCID: PMC1839849.
  12. Monaghan, L.; Longman, D.; Caceres, J.F. Translation-coupled mRNA quality control mechanisms. EMBO J. 2023, 42, e114378. https://doi.org/10.15252/embj.2023114378. PMID: 37605642; PMCID: PMC10548175.

Figure Legends

Figure 1. Supergroup 4 – ‘Paavivirinae’ Viruses not encoding a 2ANPGP are shown in blue text, those encoding a single copy of 2ANPGP are shown in black text, whilst those encoding multiple instances are shown in red text.

Figure 2. Schematic (drawn to scale) showing the positions of 2ANPGP sequences (25aa) within the genome of Aalivirus A1 polyprotein (Panel A). Artificial reporter polyprotein (boxed area) used to programme in vitro Wheat Germ Extract coupled transcription/translation systems together with translation profiles (below). The translation profile from the control FMDV constructs shows three major products: uncleaved [GFP2AGUS] and the cleavage products [GFP2A] and [GUS] whilst the Aalivirus A1 construct shows the two major cleavage products [GFP2A] and [GUS] (Panel B).

31 July 2025
MDPI INSIGHTS: The CEO's Letter #25 - 8,000 Staff Worldwide, Korea Visit, 100,000 Preprints, Malaysia Roundtable, Canada Consortium Deal

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Talent Drives Our Progress

For the first time in MDPI’s history, we now have over 8,000 colleagues across the company. I would like to take a moment to celebrate this milestone and acknowledge the driving force behind our growth and success: our people.

As the world’s leading fully open access publisher, MDPI has grown thanks to the dedication, talent, and teamwork of colleagues across the company. Already halfway through 2025, we’ve welcomed nearly 2,000 new colleagues. 

“Our achievements are also about the people behind them”

We now manage over 475 journals, with 298 receiving an Impact Factor, and hundreds more indexed in major databases, including 343 in Scopus, and 92 by PubMed. As the reach and impact of our journals continues to grow, so does the need for dedicated and qualified teams to support that growth. Thus, attracting and retaining exceptional talent remains a cornerstone of our success.

Our achievements are not just about the results of journal expansion, however: they’re about the people behind them. From our hardworking editors to our meticulous English editing and production teams – from our journal relationship specialists, public relations, marketing and communications professionals to our conference teams and the project teams behind Preprints, Scilit, SciProfiles, JAMS and more. Our success reflects the work of thousands of people showing up each day, taking pride in their work, and committed to excellence and service.

What we’re doing to support talent:

  • Investing in onboarding and training to help new colleagues feel welcomed and empowered to thrive.
  • Creating clearer career paths across all functions, from editorial to communications and beyond.
  • Launching mentorship programs and internal knowledge-sharing sessions to promote growth and collaboration.
  • Evolving our recognition and rewards programs to better celebrate your contributions.
  • Expanding our training systems and platforms.

MDPI’s in-house training department offers over 215 training courses, covering topics from editorial development to cross-cultural collaboration. In 2024 alone, we had 44 full-time trainers and 196 part-time training assistants supporting the learning and development needs of colleagues worldwide. These efforts ensure our teams are equipped with the skills and confidence to grow professionally and contribute meaningfully.

Over two-thirds of our workforce is editorial, and of our more than 5,400 editors, 87% hold a Master’s degree and 6% a PhD. Their collective contributions are central to delivering a high-quality publishing experience and supporting global academic communication.

As we celebrate this milestone, we also aim to continue on a path of steady and sustainable growth, one that balances journal expansion with investment in people, outreach, processes, and innovation. Together, we are shaping the future of open access and academic publishing. Thank you for your hard work, your ideas, and your commitment to serving the global research community.

Let’s continue working together to create a culture where great talent grows and every colleague feels valued.

Impactful Research

Visiting South Korea: Building Connections and Supporting the MDPI Seoul Office

In July, I had the opportunity to visit our team in Seoul and engage directly with academic communities in South Korea. The visit focused on deepening MDPI’s relationships with local universities, institutions, and partners, and supporting the great work of our colleagues at the MDPI Seoul office.

Korea Association of Private University Libraries (KAPUL) Conference

A highlight of the visit was our participation in the Korea Association of Private University Libraries (KAPUL) Conference, where we presented to over 100 academic librarians. I delivered a keynote speech titled “The Evolving Publishing Landscape: Open Access and Beyond,” while my colleague Dr. Jisuk Kang (Public Affairs Specialist) shared insights in her presentation, “Inside MDPI: Editorial Practices & Research Integrity.”

Facts & Figures: South Korea

  • South Korea is MDPI’s sixth-largest publishing country by article volume (over 90,000 MDPI papers published to date).
  • In 2024, Korea ranked 16th globally by total publications, and 6th (among these top 20 countries) by citation impact.
  • 52% of Korean publications in 2024 were OA – and 73% of those were Gold OA.
  • MDPI published about 20% of all OA papers from Korea in 2024.
  • Over 2,000 active Editorial Board Members from South Korea contribute to MDPI journals, with 11 Section Editors-in-Chief.
  • We currently have 11 Institutional Open Access Program agreements and two society partnerships in Korea:
    • Korean Society of Pharmaceutical Sciences and Technology (with MDPI journal Pharmaceutics)
    • Korean Tribology Society (with MDPI journal Coatings)

MDPI Seoul Office and the First Korea Salon

Our Seoul office serves as a regional hub for marketing, communications, and community engagement. It continues to grow in size and influence, prioritizing supporting scholar visits, conference sponsorships, and outreach events such as the recent MDPI Korea Salon.

The inaugural Salon, themed “Exploring Research Trends in Medical Publishing, Ethics, and AI,” brought together over 20 scholars and Editorial Board members serving MDPI journals.

Thank you to our guest speakers including Professors Young-Joon Surh of Seoul National University, Kwang-Sig Lee of Korea University, and Jin-Won Noh of Yonsei University who presented on the landscape of medicine in South Korea and across the globe. The Salon also included presentations from MDPI colleagues on Open Access, ethics, and how the IOAP can support researchers in this field.

“Our Seoul office continues to grow in size and influence”

Looking Ahead

MDPI is already the leading OA publisher in South Korea, yet challenges and misconceptions around OA and APCs remain. Visits like this one, along with the ongoing efforts of our Seoul office, are important to building understanding, trust, and long-term relationships with the local academic community.

A big thank-you to our colleagues in Seoul for their warm hospitality, professionalism, and energy! Our new office is well situated, staffed, and ready to grow. This visit marked an important step forward in our continued mission to support global research communities and advance Open Science.

Inside MDPI

Preprints.org Reaches 100,000 Preprints: A Major Milestone for MDPI and Open Science

In case you missed it, Preprints.org recently surpassed 100,000 preprints posted. This is a major milestone for our platform and one worth celebrating.

Preprints are a key pillar of the Open Science movement, which promotes transparency, equity, and faster knowledge-sharing through initiatives such as Open Access, Open Data, Open Source, and Open Peer Review. The benefits of Open Science extend beyond researchers, as they support funders, educators, policymakers, and the public in advancing discovery and innovation.

What is behind the 100,000 preprints milestone?

Since its launch in 2016, Preprints.org has grown into one of the world’s leading preprint platforms, now ranked fifth globally by publication volume.

More than 350,000 researchers have contributed, helping shape this dynamic and collaborative space for sharing early-stage research across all disciplines.

Read the full announcement here:
https://www.mdpi.com/about/announcements/12202

“Preprints.org has grown into one of the world’s leading preprint platforms”

Some quick facts worth noting:

  • About 56% of the preprints on Preprints.org are later published in peer-reviewed journals.
  • The platform is now indexed in Web of Science (Preprint Citation Index), Europe PMC, and Crossref, helping improve visibility and trust in the preprints shared.
  • Recent upgrades – including a revamped website, new features such as search subscriptions, curated reading lists, and community feedback tools (PREreview) – show our commitment to developing Preprints.org in line with researchers’ needs.

This growth and progress would not be possible without the dedication of the Preprints.org team, our Advisory Board members, screeners, and colleagues across MDPI who support the platform’s development. This milestone is a reminder of our shared mission: to accelerate scientific communication and build a more open, transparent, and inclusive research ecosystem.

I’m excited to see what’s ahead as we approach Preprints.org’s 10-year anniversary in 2026!

Coming Together for Science

Malaysia Media Roundtable: Educating on Open Access and MDPI’s Presence in Southeast Asia

At the end of June, I had the opportunity to participate in a strategic media roundtable in Kuala Lumpur, focused on raising awareness about the importance of Open Access (OA) and on MDPI’s growing presence in Southeast Asia.

We welcomed five Malaysian media outlets for an engaging private session that included presentations and open discussion.

I gave an overview of the benefits of Open Access, MDPI’s global developments, and our collaborations in Malaysia.

My colleague Yu Nwe Soe (Public Relations Specialist), presented on our editorial process, helping to clarify how MDPI supports authors and maintains research quality.

We were also joined by two local Editorial Board Members (EBMs) who offered first-hand insights into their experiences working with MDPI and how OA has shaped their publishing choices.

The discussion covered a range of questions from the press, from OA publishing models to editorial standards, and highlighted MDPI’s unique contribution to accelerating scientific communication in the region.

As the leading fully OA publisher, we see it as our responsibility to continue educating research communities and the broader public on the impact of OA, especially in emerging and high-growth academic markets.

Spotlight on Malaysia

Malaysia continues to rise as a regional research hub, with five universities ranked in the global top 200 and 11 subjects in the global top 50. In 2024, Malaysia ranked 2nd in Southeast Asia in total publication output, 10th in Asia, and 25th globally.

MDPI’s presence in Malaysia:

  • Over 21,000 research articles published to date from Malaysian institutions
  • More than 1,100 articles published in 2024 alone
  • In the period 2020–2024, 54% of Malaysia’s total publications were OA
  • 36 EBMs from Malaysia, across 27 MDPI journals
  • Around 100 conferences sponsored in Malaysia in the past five years
  • MDPI is hosting the 2nd International Conference on AI Sensors and Transducers in Kuala Lumpur (29 July- 3 August 2025)

Media Coverage & Editorial Voices

Following the roundtable, we saw positive coverage across several local outlets, with articles highlighting MDPI’s role in empowering Malaysian researchers. Notable pieces included:

Our local EBMs also shared their perspectives:

Prof. Denny Ng Kok Sum (Sunway University, EBM of MDPI journal Processes) and Prof. Lee (EBM of MDPI journal Bacteria) share their experiences with MDPI and the role Open Access plays in their publication decisions.

“We see it as our responsibility to continue educating research communities on the impact of OA”

“I didn’t want my work stuck behind a paywall.”
— Prof. Denny Ng Kok Sum, Sunway University, Processes Editorial Board Member

“Open Access opens doors for collaboration and visibility, especially in fast-developing regions like ours.”
— Prof. Lee, Bacteria Editorial Board Member

This roundtable marked another step in building trust, understanding, and collaboration in Southeast Asia. A big thank-you to the MDPI Malaysia team and all those who contributed to the event’s success.

Closing Thoughts

MDPI Signs First North American Agreement with Canadian Consortium

We are proud to announce a major milestone for MDPI Canada and an important step forward for OA in North America.

In July, our Toronto office finalized MDPI’s first North American consortium agreement with the Federal Science Libraries Network (FSLN). This is a significant achievement that strengthens our expansion in Canada and reinforces our global commitment to supporting Open Science.

This two-year agreement gives Canadian federal agencies access to MDPI’s IOAP, including discounted article processing charges for affiliated researchers across our portfolio of over 475 OA journals. It lowers barriers for Canadian scientists to share their work more openly and reach a global audience.


Ryan Siu, Institutional Partnerships Manager at MDPI.

“The Open Science landscape in Canada is rapidly evolving, with the Tri-Agency Open Access Policy set for renewal by the end of 2025. This reflects ongoing efforts to foster greater scientific transparency and accessibility at a national policy level,” says Ryan Siu, Institutional Partnerships Manager at MDPI.

“Our new agreement with FSLN represents our shared commitment to further these efforts and foster wider readership. By aligning with these initiatives, we make progress towards research that’s both inclusive and impactful, benefiting local and global communities alike.”

Participating FSLN institutions include:

  • Agriculture and Agri-Food Canada
  • Environment and Climate Change Canada
  • Health Canada
  • National Research Council Canada
  • Natural Resources Canada

By partnering with some of Canada’s largest science-based agencies, we reaffirm our goal of advancing OA across continents. We look forward to developing our support for Canadian researchers and continuing to drive progress in Open Science across North America and beyond.

Stefan Tochev
Chief Executive Officer
MDPI AG

30 July 2025
Viruses | Selected Papers on Chikungunya Virus

1. “Review on Main Arboviruses Circulating on French Guiana, An Ultra-Peripheric European Region in South America”
by Timothee Bonifay, Paul Le Turnier, Yanouk Epelboin, Luisiane Carvalho, Benoit De Thoisy, Félix Djossou, Jean-Bernard Duchemin, Philippe Dussart, Antoine Enfissi, Anne Lavergne et al.
Viruses 2023, 15(6), 1268; https://doi.org/10.3390/v15061268
Available online: https://www.mdpi.com/1999-4915/15/6/1268

2. “An Update on Current Antiviral Strategies to Combat Human Cytomegalovirus Infection”
by Kingshuk Panda, Deepti Parashar and Rajlakshmi Viswanathan
Viruses 2023, 15(6), 1358; https://doi.org/10.3390/v15061358
Available online: https://www.mdpi.com/1999-4915/15/6/1358

3. “Determinants of Chikungunya and O’nyong-Nyong Virus Specificity for Infection of Aedes and Anopheles Mosquito Vectors”
by Solène Cottis, Adrien A. Blisnick, Anna-Bella Failloux and Kenneth D. Vernick
Viruses 2023, 15(3), 589; https://doi.org/10.3390/v15030589
Available online: https://www.mdpi.com/1999-4915/15/3/589

4. “Role of the Microbiome in Aedes spp. Vector Competence: What Do We Know?”
by Qesya Rodrigues Ferreira, Fabian Fellipe Bueno Lemos, Matheus Nascimento Moura, Jéssica Oliveira de Souza Nascimento, Ana Flávia Novaes, Isadora Souza Barcelos, Larissa Alves Fernandes, Liliany Souza de Brito Amaral, Fernanda Khouri Barreto and Fabrício Freire de Melo
Viruses 2023, 15(3), 779; https://doi.org/10.3390/v15030779
Available online: https://www.mdpi.com/1999-4915/15/3/779

5. “Effect of Viral Strain and Host Age on Clinical Disease and Viral Replication in Immunocompetent Mouse Models of Chikungunya Encephalomyelitis”
by Elizabeth J. Anderson, Audrey C. Knight, Mark T. Heise and Victoria K. Baxter
Viruses 2023, 15(5), 1057; https://doi.org/10.3390/v15051057
Available online: https://www.mdpi.com/1999-4915/15/5/1057

6. “Development of Therapeutic Monoclonal Antibodies for Emerging Arbovirus Infections”
by Leonardo F. Ormundo, Carolina T. Barreto and Lilian R. Tsuruta
Viruses 2023, 15(11), 2177; https://doi.org/10.3390/v15112177
Available online: https://www.mdpi.com/1999-4915/15/11/2177

7. “Seroprevalence of IgG Antibodies Directed against Dengue, Chikungunya and West Nile Viruses and Associated Risk Factors in Madagascar, 2011 to 2013”
by Anaïs Broban, Marie-Marie Olive, Michael Luciano Tantely, Anne-Claire Dorsemans, Fanjasoa Rakotomanana, Jean-Pierre Ravalohery, Christophe Rogier, Jean-Michel Heraud and Soa Fy Andriamandimby
Viruses 2023, 15(8), 1707; https://doi.org/10.3390/v15081707
Available online: https://www.mdpi.com/1999-4915/15/8/1707

8. “Deubiquitinating Enzyme Inhibitors Block Chikungunya Virus Replication”
by Lady S. López, Eliana P. Calvo and Jaime E. Castellanos
Viruses 2023, 15(2), 481; https://doi.org/10.3390/v15020481
Available online: https://www.mdpi.com/1999-4915/15/2/481

9. “Serological and Molecular Epidemiology of Chikungunya Virus Infection in Vietnam, 2017–2019”
by Thanh Vu Nguyen, Mya Myat Ngwe Tun, Minh Thang Cao, Huy Manh Dao, Chan Quang Luong, Thi Kim Loan Huynh, Thi Thanh Thuong Nguyen, Thi Nhu Dao Hoang, Kouichi Morita et al.
Viruses 2023, 15(10), 2065; https://doi.org/10.3390/v15102065
Available online: https://www.mdpi.com/1999-4915/15/10/2065

10. “The Innate Immune Response in DENV- and CHIKV-Infected Placentas and the Consequences for the Fetuses: A Minireview”
by Felipe de Andrade Vieira Alves, Priscila Conrado Guerra Nunes, Laíza Vianna Arruda, Natália Gedeão Salomão and Kíssila Rabelo
Viruses 2023, 15(9), 1885; https://doi.org/10.3390/v15091885
Available online: https://www.mdpi.com/1999-4915/15/9/1885

11. “Spatio-Temporal Cluster Detection of Dengue, Chikungunya, and Zika Viruses’ Infection in Rio de Janeiro State from 2010 to 2019”
by Paula Maria Pereira de Almeida, Daniel Cardoso Portela Câmara, Aline Araújo Nobre, Tania Ayllón, Mário Sérgio Ribeiro, Cristina Maria Giordano Dias, Eduardo Mesquita Peixoto, Maíra Mendonça da Rocha, Silvia Carvalho and Nildimar Alves Honório
Viruses 2023, 15(7), 1496; https://doi.org/10.3390/v15071496
Available online: https://www.mdpi.com/1999-4915/15/7/1496

28 July 2025
World Hepatitis Day—“Hepatitis: Let’s Break It Down”, 28 July 2025


World Hepatitis Day is observed each year on 28 July to raise awareness of viral hepatitis, a type of inflammation of the liver that causes severe liver disease and liver cancer.

The theme for 2025—“Hepatitis: Let’s Break It Down”—calls for urgent action to dismantle the financial, social and systemic barriers, including stigma, that stand in the way of hepatitis elimination and liver cancer prevention.

Chronic hepatitis B and C silently cause liver damage and cancer—despite them being preventable, treatable, and, in the case of hepatitis C, curable. The theme emphasizes the need to simplify, scale up, and integrate hepatitis services—vaccination, safe injection practices, harm reduction and especially testing and treatment—into national health systems.

The campaign is a reminder that we must act now to expand access, integrate care, and end hepatitis as a public health problem by 2030.

In recognition of this important day, we recommend the following related articles, Special Issues, and journals spanning multidisciplinary fields, including clinical medicine. We believe that promoting such research contributes to enhanced public awareness and a greater understanding of viral hepatitis, an inflammation of the liver that causes severe liver disease and liver cancer.


Biology & Life Sciences

Medicine & Pharmacology


Curcumin Nanocarriers in the Protection Against Iron- and Alcohol-Induced Oxidative Stress in a Cellular Model of Liver Disease
by Lucy Petagine, Mohammed G. Zariwala, Satyanarayana Somavarapu, Stefanie Ho Yi Chan and Vinood B. Patel
Biology 2025, 14(5), 455; https://doi.org/10.3390/biology14050455

Hepatic Estrogen Receptor Alpha Overexpression Protects Against Hepatic Insulin Resistance and MASLD
by Ester S. Alves, Jessica D. M. Santos, Alessandra G. Cruz, Felipe N. Camargo, Carlos H. Z. Talarico, Anne R. M. Santos, Carlos A. A. Silva, Henrique J. N. Morgan, Sandro L. Matos, Layanne C. C. Araujo et al.
Pathophysiology 2025, 32(1), 1; https://doi.org/10.3390/pathophysiology32010001

Change in Estimated Glomerular Filtration Rate After Direct-Acting Antiviral Treatment in Chronic Hepatitis C Patients
by Gantogtokh Dashjamts, Amin-Erdene Ganzorig, Yumchinsuren Tsedendorj, Dolgion Daramjav, Enkhmend Khayankhyarvaa, Bolor Ulziitsogt, Otgongerel Nergui, Ganchimeg Dondov, Tegshjargal Badamjav, Tulgaa Lonjid et al.
Diseases 2025, 13(2), 26; https://doi.org/10.3390/diseases13020026

Effects of SARS-CoV-2 Spike S1 Subunit on the Interplay Between Hepatitis B and Hepatocellular Carcinoma Related Molecular Processes in Human Liver
by Giovanni Colonna
Livers 2025, 5(1), 1; https://doi.org/10.3390/livers5010001

Liver Cancer Neuroscience: Regulating Liver Tumors via Selective Hepatic Vagotomy
by Kylynda C. Bauer, Shadin Ghabra, Chi Ma Lee Chedester and Tim F. Greten
Methods Protoc. 2024, 7(6), 99; https://doi.org/10.3390/mps7060099

Role of Circulating microRNAs in Liver Disease and HCC: Focus on miR-122
by Francesco Colaianni, Veronica Zelli, Chiara Compagnoni, Martina Sara Miscione, Mario Rossi, Davide Vecchiotti, Monica Di Padova, Edoardo Alesse, Francesca Zazzeroni and Alessandra Tessitore
Genes 2024, 15(10), 1313; https://doi.org/10.3390/genes15101313

Impact of Hepatitis Delta Virus Infection on the Selection of Hepatitis B Surface Antigen Mutations
by Kabo Baruti,Wonderful T. Choga, Bonolo B. Phinius, Basetsana Phakedi, Lynnette Bhebhe, Gorata G. A. Mpebe, Patience C. Motshosi, Tsholofelo Ratsoma, Sikhulile Moyo, Mosimanegape Jongman et al.
Genes 2024, 15(8), 982; https://doi.org/10.3390/genes15080982

NAFLD/MASLD and the Gut–Liver Axis: From Pathogenesis to Treatment Options
by Natalia G. Vallianou, Dimitris Kounatidis, Sotiria Psallida, Nikolaos Vythoulkas-Biotis, Andreas Adamou, Tatiana Zachariadou, Sofia Kargioti, Irene Karampela and Maria Dalamaga
Metabolites 2024, 14(7), 366; https://doi.org/10.3390/metabo14070366

miRNA Expression and HCC Occurrence in HCV Cirrhotic Patients Treated with Direct Acting Antivirals
by Antonietta Romano, Alessandra Brocca, Zoe Mariño, Sofía Pérez-del-Pulgar, Sabela Lens, Loreto Boix, María Reig, Jordi Bruix, Giulio Ceolotto, Valeria Calvino et al.
Livers 2024, 4(2), 275-286; https://doi.org/10.3390/livers4020020

The Full-Genome Analysis and Generation of an Infectious cDNA Clone of a Genotype 6 Hepatitis E Virus Variant Obtained from a Japanese Wild Boar: In Vitro Cultivation in Human Cell Lines
by Putu Prathiwi Primadharsini, Masaharu Takahashi, Tsutomu Nishizawa, Yukihiro Sato, Shigeo Nagashima, Kazumoto Murata and Hiroaki Okamoto
Viruses 2024, 16(6), 842; https://doi.org/10.3390/v16060842

Hepatitis C Prevalence and Birth Outcomes among Pregnant Women in the United States: A 2010–2020 Population Study
by Paul Wasuwanich, Songyos Rajborirug, Robert S. Egerman, Tony S. Wen and Wikrom Karnsakul
Pathogens 2024, 13(4), 321; https://doi.org/10.3390/pathogens13040321

Prospects for Controlling Hepatitis B Globally
by Vicente Soriano, Víctor Moreno-Torres, Ana Treviño, Fernando de Jesús, Octavio Corral and Carmen de Mendoza
Pathogens 2024, 13(4), 291; https://doi.org/10.3390/pathogens13040291

Longterm Outcome of Therapeutic Vaccination with a Third Generation Pre-S/S HBV Vaccine (PreHevbrioR) of Chronically HBV Infected Patients
by Hedwig Roggendorf, Daniel Shouval, Michael Roggendorf and Guido Gerken
J. Pers. Med. 2024, 14(4), 364; https://doi.org/10.3390/jpm14040364

NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic–Metabolic Interplay
by Simona Cernea
Life 2024, 14(2), 272; https://doi.org/10.3390/life14020272

Updated Clinical Guidelines on the Management of Hepatitis C Infection in Children
by Chaowapong Jarasvaraparn, Christopher Hartley and Wikrom Karnsakul
Pathogens 2024, 13(2), 180; https://doi.org/10.3390/pathogens13020180

Non-Invasive Assessment of Liver Fibrosis in Hepatitis B Patients
by Chinmay Bera, Nashla Hamdan-Perez and Keyur Patel
J. Clin. Med. 2024, 13(4), 1046; https://doi.org/10.3390/jcm13041046

Real-World Utilization of Corticosteroids in Severe Alcoholic Hepatitis: Eligibility, Response, and Outcomes
by Ana-Maria Singeap, Horia Minea, Oana Petrea, Madalina-Andreea Robea, Ioana-Miruna Balmuș, Raluca Duta, Ovidiu-Dumitru Ilie, Carmen Diana Cimpoesu, Carol Stanciu and Anca Trifan
Medicina 2024, 60(2), 311; https://doi.org/10.3390/medicina60020311

Autoimmune Hepatitis: A Diagnostic and Therapeutic Overview
by Lydia A. Mercado, Fernando Gil-Lopez, Razvan M. Chirila and Denise M. Harnois
Diagnostics 2024, 14(4), 382; https://doi.org/10.3390/diagnostics14040382

Hepatoprotective Effects of Flavonoids against Benzo[a]Pyrene-Induced Oxidative Liver Damage along Its Metabolic Pathways
by Min Kim, Seung-Cheol Jee and Jung-Suk Sung
Antioxidants 2024, 13(2), 180; https://doi.org/10.3390/antiox13020180

Enhancing Liver Delivery of Gold Nanoclusters via Human Serum Albumin Encapsulation for Autoimmune Hepatitis Alleviation
by Cong Meng, Yu Liu, Yuping Ming, Cao Lu, Yanggege Li, Yulu Zhang, Dongdong Su, Xueyun Gao and Qing Yuan
Pharmaceutics 2024, 16(1), 110; https://doi.org/10.3390/pharmaceutics16010110

Hepatitis B Virus Reactivation with Immunosuppression: A Hidden Threat?
by Sama Anvari and Keith Tsoi
J. Clin. Med. 2024, 13(2), 393; https://doi.org/10.3390/jcm13020393

Metabolic Dysfunction-Associated Fatty Liver Disease and Chronic Viral Hepatitis: The Interlink
by Cornelius J. Fernandez, Mohammed Alkhalifah, Hafsa Afsar and Joseph M. Pappachan
Pathogens 2024, 13(1), 68; https://doi.org/10.3390/pathogens13010068

A Case Report: Idiopathic or Drug-Induced Autoimmune Hepatitis—Can We Draw a Line?
by Dorotea Božić, Ante Tonkić, Jr,Katarina Vukojevic and Maja Radman
Clin. Pract. 2023, 13(6), 1393–1399; https://doi.org/10.3390/clinpract13060125

Liver dECM–Gelatin Composite Bioink for Precise 3D Printing of Highly Functional Liver Tissues
by Min Kyeong Kim, Wonwoo Jeong and Hyun-Wook Kang
J. Funct. Biomater. 2023, 14(8), 417; https://doi.org/10.3390/jfb14080417

Viral Hepatitis: Diagnosis, Treatment and Management”
Guest Editors: Dr. Veysel Tahan and Dr. Resat Ozaras
Submission deadline: 31 August 2025

New Insights into Diagnosis and Therapeutic Strategies for Chronic Liver Diseases”
Guest Editor: Prof. Dr. Cristina Marginean
Submission deadline: 20 October 2025

“The Surveillance, Prevention, and Treatment of Viral Hepatitis: Looking Forward to Global Elimination”
Guest Editor: Dr. Melanie Deutsch
Submission deadline: 31 October 2025

“Viral Hepatitis and Therapeutic Strategies
Guest Editor: Dr. Arshi Khanam
Submission deadline: 20 November 2025

“Genetic Analysis of Hepatitis Virus Infection”
Guest Editors: Prof. Dr. Dan Florin Mihǎilescu and Dr. Maria Alexandra Mernea
Submission deadline: 20 November 2025

“Oxidative Stress in Hepatic Diseases”
Guest Editor: Dr. Miquel Mulero
Submission deadline: 21 November 2025

“Viral Hepatitis Among Specific Populations: Epidemiology, Transmission, Treatment, and Prevention”
Guest Editor: Dr. Aldemir B. Oliveira-Filho
Submission deadline: 15 December 2025

Biology of Liver Diseases
Guest Editors: Dr. Tadashi Namisaki and Dr. Hiroaki Takaya
Submission deadline: 20 December 2025

Hepatitis E Virus (HEV) Infection Among Humans and Animals: Epidemiology, Clinical Characteristics, Treatment and Prevention—2nd Edition
Guest Editors: Dr. Jelena Prpić and Dr. Magdalena Baymakova
Submission deadline: 31 December 2025

“Human Hepatitis Viruses and Their Animal Homologues”
Guest Editors: Dr. Bo Wang and Prof. Dr. Xinglou Yang
Submission deadline: 31 December 2025

Advances in Hepatitis: Prevention, Treatment, and Global Health Impact
Guest Editors: Dr. Michał Brzdęk, Prof. Dr. Dorota Zarębska-Michaluk and Dr. Krystyna Dobrowolska
Submission deadline: 28 January 2026

“Pathogenesis of Viral Hepatitis”
Guest Editor: Dr. Po-Yuan Ke
Submission deadline: 28 February 2026

Liver Diseases: Diagnosis and Treatment in the Era of Personalized Medicine
Guest Editors: Dr. María Teresa Arias-Loste and Dr. Armando Raúl Guerra-RuizSubmission deadline: 30
April 2026

“Gastrointestinal and Liver Diseases: New Advances in Diagnosis and Prognosis”
Guest Editor: Prof. Dr. Carmen Fierbinteanu-Braticevici
Submission deadline: closed (31 December 2023)

18 July 2025
Meet Us at the 12th China Veterinary Conference, 21–24 August 2025, Xi’an, China


Conference:
The 12th China Veterinary Conference
Date: 21 August–24 August 2025
Location: Xi’an, China

We are pleased to announce that MDPI will be participating in the 12th China Veterinary Conference in Xi’an, China, from 21 August to 24 August 2025.

The China Veterinary Congress is a large-scale conference held for all livestock and veterinary practitioners across the country. Its purpose is to enhance the overall quality of livestock health during breeding, animal disease prevention and control, animal disease diagnosis and treatment, and veterinary public health in China. The 2024 Livestock and Veterinary Products Exhibition has also been held concurrently to this conference. Since 2010, the China Veterinary Congress has successfully held eleven sessions, providing a platform for experts to conduct lectures, a display stage for enterprises, and a learning platform for the audience. The Congress has become a comprehensive and integrated platform that combines learning, communication, display, training, and competition.

The following MDPI journals will be represented at the conference:

If you are planning to attend the conference, please feel free to start a conversation with us. We invite all attendees to visit MDPI’s booth and meet with our esteemed Editorial Board Members who will be present.

11 July 2025
Viruses | Selected Papers on African Swine Fever Virus
 

1. “Characterization of a Novel African Swine Fever Virus p72 Genotype II from Nigeria”
by Aruna Ambagala, Kalhari Goonewardene, Lindsey Lamboo, Melissa Goolia, Cassidy Erdelyan, Mathew Fisher, Katherine Handel, Oliver Lung, Sandra Blome, Jacqueline King et al.
Viruses 2023, 15(4), 915; https://doi.org/10.3390/v15040915
Available online: https://www.mdpi.com/1999-4915/15/4/915

2. “A Spontaneously Occurring African Swine Fever Virus with 11 Gene Deletions Partially Protects Pigs Challenged with the Parental Strain”
by Tomoya Kitamura, Kentaro Masujin, Reiko Yamazoe, Ken-ichiro Kameyama, Mizuki Watanabe, Mitsutaka Ikezawa, Manabu Yamada and Takehiro Kokuho
Viruses 2023, 15(2), 311; https://doi.org/10.3390/v15020311
Available online: https://www.mdpi.com/1999-4915/15/2/311

3. “African Swine Fever Virus Interaction with Host Innate Immune Factors”
by Ayoola Ebenezer Afe, Zhao-Ji Shen, Xiaorong Guo, Rong Zhou and Kui Li
Viruses 2023, 15(6), 1220; https://doi.org/10.3390/v15061220
Available online: https://www.mdpi.com/1999-4915/15/6/1220

4. “Point-of-Care Testing for Sensitive Detection of the African Swine Fever Virus Genome”
by Ahmed Elnagar, Sandra Blome, Martin Beer and Bernd Hoffmann
Viruses 2022, 14(12), 2827; https://doi.org/10.3390/v14122827
Available online: https://www.mdpi.com/1999-4915/14/12/2827

5. “I329L: A Dual Action Viral Antagonist of TLR Activation Encoded by the African Swine Fever Virus (ASFV)”
by Sílvia Correia, Pedro Luís Moura, Sónia Ventura, Alexandre Leitão and Robert Michael Evans Parkhouse
Viruses 2023, 15(2), 445; https://doi.org/10.3390/v15020445
Available online: https://www.mdpi.com/1999-4915/15/2/445

6. “The Long-Jumping of African Swine Fever: First Genotype II Notified in Sardinia, Italy”
by Silvia Dei Giudici, Federica Loi, Sonia Ghisu, Pier Paolo Angioi, Susanna Zinellu, Mariangela Stefania Fiori, Francesca Carusillo, Diego Brundu, Giulia Franzoni, Giovanni Maria Zidda et al.
Viruses 2024, 16(1), 32; https://doi.org/10.3390/v16010032
Available online: https://www.mdpi.com/1999-4915/16/1/32

7. “Functional Landscape of African Swine Fever Virus–Host and Virus–Virus Protein Interactions”
by Katarzyna Magdalena Dolata, Gang Pei, Christopher L. Netherton and Axel Karger
Viruses 2023, 15(8), 1634; https://doi.org/10.3390/v15081634
Available online: https://www.mdpi.com/1999-4915/15/8/1634

8. “Developing an Indirect ELISA for the Detection of African Swine Fever Virus Antibodies Using a Tag-Free p15 Protein Antigen”
by Zhi Wu, Huipeng Lu, Dewei Zhu, Jun Xie, Fan Sun, Yan Xu, Hua Zhang, Zhijun Wu, Wenlong Xia and Shanyuan Zhu
Viruses 2023, 15(9), 1939; https://doi.org/10.3390/v15091939
Available online: https://www.mdpi.com/1999-4915/15/9/1939

9. “Mammalian Cell-Line-Expressed CD2v Protein of African Swine Fever Virus Provides Partial Protection against the HLJ/18 Strain in the Early Infection Stage”
by Rong-Hong Hua, Jing Liu, Shu-Jian Zhang, Ren-Qiang Liu, Xian-Feng Zhang, Xi-Jun He, Dong-Ming Zhao and Zhi-Gao Bu
Viruses 2023, 15(7), 1467; https://doi.org/10.3390/v15071467
Available online: https://www.mdpi.com/1999-4915/15/7/1467

10. “Evaluation of the Deletion of the African Swine Fever Virus Gene O174L from the Genome of the Georgia Isolate”
by Elizabeth Ramirez-Medina, Lauro Velazquez-Salinas, Ayushi Rai, Nallely Espinoza, Alyssa Valladares, Ediane Silva, Leeanna Burton, Edward Spinard, Amanda Meyers, Guillermo Risatti et al.
Viruses 2023, 15(10), 2134; https://doi.org/10.3390/v15102134
Available online: https://www.mdpi.com/1999-4915/15/10/2134

Back to TopTop